Cohance Lifesciences Share price

COHANCE

Healthcare Large

878.4

11.55 (-1.30%)

NSE

BSE

Last updated on 20 Oct, 2025 | 15:44 IST

BUYSELL

Today's High

894.55

Today's Low

874.15

52 Week Low

856.00

52 Week High

1360.00

The current prices are delayed, login to your account for live prices

Cohance Lifesciences Share Key Metrics

Volume

1.70 L

Market Cap

33604.70 CR

LTQ@LTP

2@878.40

ATP

881.59 Var Margin

18.18 %

Circuit Range

712-1067.9

Delivery %

39.83 %

Value

15.02 CR

ASM/GSM

No

Market Lot

1

Cohance Lifesciences Fundamentals

P/E Ratio

133.18

P/B Ratio

19.6

Div. Yield

0

Sector P/E

37.42

Sector P/B

3.53

Sec. Div. Yield

0.55

Cohance Lifesciences Resistance and Support

Pivot 997.07

Resistance

First Resistance

1012.14

Second Resistance

1033.57

Third Resistance

1048.64

Support

First Support

975.64

Second Support

960.57

Third Support

939.14

Cohance Lifesciences Futures & Options

Data Not Found

Cohance Lifesciences Shareholding Pattern

2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26

Total Promoters

Segment

Percent

Total Promoters

57.49%

Mutual Fund

16.49%

Insurance

3.95%

Foreign Institutional Investors

6.51%

Domestic Institutional Investors

0.39%

Retail

15.17%

Others

0%

Total Promoters

MAR '25

50.1%

JUN '25

66.41%

SEP '25

57.49%

Cohance Lifesciences Corporate Actions

Date	Agenda
2025-11-12	Quarterly Results
2025-08-13	Quarterly Results
2025-05-28	Audited Results
2025-02-12	Quarterly Results
2024-11-12	Quarterly Results
2024-08-09	Quarterly Results

Cohance Lifesciences News

National Company Law Tribunal clears Casper Pharma’s merger with Suven Pharmaceuticals

Oct 30 2024 05:57:11

NSE : 17945

BSE : 543064

ISIN : INE03QK01018

Cohance Lifesciences Management

Name	Position
Mr. Vivek Sharma	Executive Chairman
Dr. V Prasada Raju	Managing Director

Cohance Lifesciences Similar Stocks

Glaxosmithkline Pharmaceuticals Ltd.

2745.70

2.80 (0.10%)

Anthem Biosciences Ltd.

727.10

-30.50 (4.03%)

Global Health Ltd.

1382.70

11.00 (0.80%)

Aster DM Healthcare Ltd.

718.20

15.75 (2.24%)

Narayana Hrudayalaya Ltd.

1772.00

16.60 (0.95%)

Ipca Laboratories Ltd.

1271.00

-15.30 (1.19%)

Gland Pharma Ltd.

1924.80

-13.00 (0.67%)

Ajanta Pharma Ltd.

2431.00

-7.50 (0.31%)

Krishna Institute of Medical Sciences Ltd

719.90

0.00 (0.00%)

JB Chemicals & Pharmaceuticals Ltd.

1691.20

-2.20 (0.13%)

Cohance Lifesciences FAQs

The Buying Price of Cohance Lifesciences share is 878.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 133.18. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Cohance Lifesciences shares is 19.6. Useful to assess the stock's value relative to its book value.

To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 37.42 & 3.53 with sector averages, along with growth rates and financial metrics.

The Market Cap of Cohance Lifesciences is 33604.70 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Cohance Lifesciences share price is 1360.00 & 856.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Cohance Lifesciences belongs to the Healthcare sector.